Literature DB >> 23912953

Do patients with head and neck human papillomavirus-related carcinoma need a different treatment approach?

Jon Cacicedo Fernandez de Bobadilla1, Pedro Bilbao.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23912953     DOI： 10.1007/s10147-013-0600-3

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN： 1341-9625            Impact factor:   3.402


× No keyword cloud information.
  7 in total

1.  Human papillomavirus and survival of patients with oropharyngeal cancer.

Authors:  K Kian Ang; Jonathan Harris; Richard Wheeler; Randal Weber; David I Rosenthal; Phuc Felix Nguyen-Tân; William H Westra; Christine H Chung; Richard C Jordan; Charles Lu; Harold Kim; Rita Axelrod; C Craig Silverman; Kevin P Redmond; Maura L Gillison
Journal:  N Engl J Med       Date:  2010-06-07       Impact factor: 91.245

2.  The prognostic significance of p16 overexpression in oropharyngeal squamous cell carcinoma: implications for treatment strategies and future clinical studies.

Authors:  J A Langendijk; A Psyrri
Journal:  Ann Oncol       Date:  2010-08-17       Impact factor: 32.976

3.  Controversies in treatment deintensification of human papillomavirus-associated oropharyngeal carcinomas: should we, how should we, and for whom?

Authors:  Harry Quon; Arlene A Forastiere
Journal:  J Clin Oncol       Date:  2013-01-07       Impact factor: 44.544

Review 4.  Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.

Authors:  Kie Kian Ang; Erich M Sturgis
Journal:  Semin Radiat Oncol       Date:  2012-04       Impact factor: 5.934

5.  Improved survival of Japanese patients with human papillomavirus-positive oropharyngeal squamous cell carcinoma.

Authors:  Takatsugu Mizumachi; Satoshi Kano; Tomohiro Sakashita; Hiromitsu Hatakeyama; Seigo Suzuki; Akihiro Homma; Nobuhiko Oridate; Satoshi Fukuda
Journal:  Int J Clin Oncol       Date:  2012-08-31       Impact factor: 3.402

6.  The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial.

Authors:  Pernille Lassen; Jesper G Eriksen; Annelise Krogdahl; Marianne Hamilton Therkildsen; Benedicte P Ulhøi; Marie Overgaard; Lena Specht; Elo Andersen; Jørgen Johansen; Lisbeth J Andersen; Cai Grau; Jens Overgaard
Journal:  Radiother Oncol       Date:  2011-03-21       Impact factor: 6.280

7.  Quality of life of oropharyngeal cancer patients with respect to treatment strategy and p16-positivity.

Authors:  Martina A Broglie; Alex Soltermann; Sarah R Haile; Christof Röösli; Gerhard F Huber; Stephan Schmid; Sandro J Stoeckli
Journal:  Laryngoscope       Date:  2012-11-14       Impact factor: 3.325
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.